⌘K
Loading ticker…
As of 2026-08-24, Collegium Pharmaceutical, Inc. Common Stock (COLL) has a 3-month relative strength percentile of 20 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 39. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.9%, relative volume 1.00×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
COLL is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -18.3% / -29.7%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
COLL appears in 1 ETF as of Jun 2026: PSC at 0.07% weight, $2M notional.
Held by 108 ETFs · $296M across latest filings · largest weight 4.39% (ABLS).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.07% | $2M | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | COLL Jan avg: 9.85% median: 9.60% win: 75% σ: 9.16% n: 4 2022-04-12 → 2026-07-31 | COLL Feb avg: -3.24% median: -7.39% win: 25% σ: 9.92% n: 4 2022-04-12 → 2026-07-31 | COLL Mar avg: -5.43% median: -3.41% win: 50% σ: 12.12% n: 4 2022-04-12 → 2026-07-31 | COLL Apr avg: -6.72% median: -4.87% win: 20% σ: 7.61% n: 5 2022-04-12 → 2026-07-31 | COLL May avg: -2.16% median: -2.98% win: 20% σ: 6.72% n: 5 2022-04-12 → 2026-07-31 | COLL Jun avg: 3.43% median: 1.48% win: 60% σ: 7.04% n: 5 2022-04-12 → 2026-07-31 | COLL Jul avg: 4.29% median: 0.98% win: 60% σ: 9.34% n: 5 2022-04-12 → 2026-07-31 | COLL Aug avg: 8.71% median: 2.58% win: 75% σ: 14.22% n: 4 2022-04-12 → 2026-07-31 (current) | COLL Sep avg: -5.70% median: -6.72% win: 25% σ: 4.70% n: 4 2022-04-12 → 2026-07-31 | COLL Oct avg: 0.15% median: 0.12% win: 50% σ: 9.91% n: 4 2022-04-12 → 2026-07-31 | COLL Nov avg: 14.67% median: 19.85% win: 75% σ: 17.59% n: 4 2022-04-12 → 2026-07-31 | COLL Dec avg: 4.82% median: 2.63% win: 50% σ: 11.33% n: 4 2022-04-12 → 2026-07-31 |